Virogin Biotech Revenue and Competitors
Estimated Revenue & Valuation
- Virogin Biotech's estimated annual revenue is currently $6.4M per year.
- Virogin Biotech's estimated revenue per employee is $155,000
Employee Data
- Virogin Biotech has 41 Employees.
- Virogin Biotech grew their employee count by -38% last year.
Virogin Biotech's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Scientific Officer | Reveal Email/Phone |
2 | Chief Scientific Officer | Reveal Email/Phone |
3 | Associate Director | Reveal Email/Phone |
4 | Director Research | Reveal Email/Phone |
5 | Operation Assistant | Reveal Email/Phone |
6 | Finance & HR administrator | Reveal Email/Phone |
7 | Laboratory Technician | Reveal Email/Phone |
8 | Research Assistant | Reveal Email/Phone |
9 | Senior Accountant | Reveal Email/Phone |
10 | Senior Research Technician | Reveal Email/Phone |
Virogin Biotech Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $30M | 155 | -5% | $132.7M | N/A |
#2 | $10.9M | 70 | -5% | $2M | N/A |
#3 | $15.7M | 101 | 5% | N/A | N/A |
#4 | $11M | 71 | 8% | N/A | N/A |
#5 | $123.9M | 571 | -11% | $94.5M | N/A |
#6 | $22.5M | 320 | 0% | $845.8M | N/A |
#7 | $9.8M | 41 | -68% | $494.1M | N/A |
#8 | $443.8M | 821 | 11% | $371.2M | N/A |
#9 | $33.6M | 217 | 19% | N/A | N/A |
#10 | $100M | 461 | 8% | $871.5M | N/A |
What Is Virogin Biotech?
Virogin Biotech aims to be a global, best-in-class oncolytic virus company that creates impactful drugs for patients of the highest medical need. Our platform technology focuses on creating long-lasting antitumor immunity by capitalizing on a robust, transient antiviral immune response through a synergy with multiple payload expression. Virogin is designing a more potent oncolytic virus, expressing optimized payloads to enhance the systemic antitumor immunity in relapsed/refractory cancers. Led by our leadership team with over 25 years of experience in fundamental research, translational and clinical development of immunotherapy & oncolytic virotherapy, we are determined to bring our novel therapies for relapsed/refractory cancers to market.
keywords:N/A
N/A
Total Funding
41
Number of Employees
$6.4M
Revenue (est)
-38%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Richmond
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.2M | 41 | -5% | $8M |
#2 | $9.5M | 41 | 28% | N/A |
#3 | $8.9M | 41 | 3% | N/A |
#4 | $9.5M | 41 | 11% | N/A |
#5 | $4.9M | 41 | 11% | N/A |